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Abstract 
Objective: In this study we investigated the epidemiology of MS and some related environmental 
factors in Kerman province, southeastern Iran. Methods: The MS diagnosis was based on the revised 
Mc-Donald criteria. The patients were those registered at the Iran MS society, Kerman branch; those 
in the MS registration centers of Kerman and Rafsanjan University of Medical Sciences, and the 
Department of Neurology at Shafa Medical Center were studied. Results: The prevalence of MS was 
31.5 per 100,000 population in Kerman province, and 57.3 per 100,000 population in Kerman city. 
The male to female ratio was 1:3. Average age at onset was 28.35 years, and 3.9% of cases were 
early onset at ≤16 years of age. A linear relationship was observed between prevalence and average 
environmental temperature as prevalence tended to be lower in areas where the annual average 
temperature was higher. However, in the town of Shahrbabak which has cold weather, prevalence 
was low, which might be related to the presence of copper in this area. Average disability was 4.5± 
1.9 (4.83 ± 1.9 in men and 4.26 ± 1.8 in women, p=0.0035) on the Kurtzke Disability Status Scale. 
The mean duration of illness was 8.2 ± 1 year. Almost all patients in this study used beta-interferon 
for a period of at least 4 years. 
Conclusion: The prevalence of MS in Kerman province was 31.5 per 100,000 people. A linear 
relationship between an increase in prevalence and low average temperature was observed. Copper 
may have a preventive effect.
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INTRODUCTION
Multiple sclerosis (MS) is a complex neurological 
condition with associated loss of myelin and 
axons.1 This disease is the most common human 
demyelinating illness2,3 and afflicts twice as 
many women as men.4 The average age at onset 
of illness is 30 years3, and almost 1,000,000 
people in the world between the ages of 17–65 
have been afflicted.5 The onset of MS typically 
is in young adults, and thus it is associated with 
long term physical effects. The socio-economic 
impact may be greater than that of Alzheimer’s 
and myocardial infarction due to its extended 
duration of illness.6 The highest prevalence of 
MS is in Europe and North America. However, 
evidence shows an increase of this disease in 
arid regions and developing countries.7 The MS 
prevalence rate in Tehran-Iran is estimated to be 
51.9 per 100,000 population; and in Isfahan-Iran, 
43.8 per 100,000 population.8,9
 It is believed that MS is a complex disease 
caused by the interaction of genetics and 
the environmental factors.10 There are many 
environmental factors that are thought to affect 
MS. They are: viral infections11, smoking12, 
improved hygiene13, ultraviolet radiation14 such 
as living in high latitudes areas where ultraviolet 
radiation is low15, vitamin D metabolism16, 
accumulation of copper, lead, and iron; reduction 
in zinc, magnesium, selenium, vitamins B2, B6, 
D, E, and essential fatty acids.17,18 In this study, 
we investigated how temperature is associated 
with MS, focusing on the vast province of Kerman 
which is composed of different cities of varying 
climates.
METHOD
All MS patients, whose diagnosis was based on the 
revised Mc-Donald criteria, which were registered 
at the Iranian MS society, Kerman branch, as well 
as those in the MS registration centers of Kerman 
and Rafsanjan Medical Sciences Universities, and 
the Department of Neurology at Shafa Medical 
Center, were recruited. Telephone contacts were 
made with the patients and their families to 
ascertain the patients’ conditions and particularly 
if any changes might have occurred after their 
last follow-up. If necessary, they were invited 
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for a repeat examination. Patients were asked 
where they lived before the first MS attack, and 
a detailed examination of their clinical records at 
the time of the first attack was conducted. Their 
average daily exposure to sunlight was evaluated. 
The duration of sun exposure was the period in 
which the patients were in open space during 
daytime (without any obstacles blocking the sun 
light), as stated by the patients or their relatives. 
Iranian women were mostly covered by clothing 
except for their faces and hands. Most patients 
were in close contact with the MS society, which 
facilitated obtaining of information. The level of 
disability of patients was assessed based on the 
Kurtzke Disability Status Scale (EDSS). 
 Kerman province is a vast region with an area of 
714,181 square kilometers located in southeastern 
Iran (latitude 30° north).19 The climate varies 
in different parts of Kerman province. For this 
study, average temperatures in the main cities 
were taken. In the northern, northwestern, and 
central areas, the weather is dry with mild 
temperatures. In the south and southeastern parts, 
the climate is humid with higher temperatures. 
In Kerman city and the suburbs, the climate 
is dry with semi-mild temperatures. Cities of 
Kerman, Baft, and Shahrbabak, were colder with 
an average temperature < 16°C. The cities of 
Sirjan, Rafsanjan, and Zarand, were mild with an 
average temperature range of 16–20°C, and cities 
of Kahnuj, Bam, and Jiroft, were warm with an 
average temperature of >20°C. The city of Bardsir, 
with low population, close proximity to Kerman 
and similarity of climate was considered part of 
the city of Kerman.20 Kerman’s population in 2011 
was estimated to be 3 million.21 We determined 
the prevalence of MS in the study area for the 
first six months of 2011. Patients were divided 
into relapsing-remitting MS (RRMS), primary-
progressive MS (PPMS), secondary-progressive 
MS (SPMS), and Devic’s syndrome.22 The results 
were analyzed using descriptive analysis and 
t-tests in some instances.
RESULTS
The total number of registered patients in the 
province was 932. The distribution with mean 
temperature in different cities is shown in Table 1.
MS prevalence in Kerman province was 31.5 per 
100, 000 people. The male to female ratio of the 
MS patients was 1:3. The prevalence of MS in 
the various cities and their average temperature 
is shown in Figure 1.
 The average age at onset of illness was 28.4 
years (29 ± 8.7 for men and 28 ± 8.3 for women, 
P<0.05). The proportion of cases with onset of 
illness ≤16 years old was 3.9%. The average EDSS 
Mean temperature: Celsius temperature scale.
Per/100000: prevalence of MS
Figure 1. Relation of mean temperature and prevalence of MS
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of the 762 patients (from 932 patients) examined 
was 4.5 ± 1.9 (4.8 ± 1.9 for men and 4.4 ± 1.8 
for women, p=0.0035). The mean duration of 
illness was 8.2 ± 1 year (8.4 ± 1.2 for men and 
8.7 ± 0.5 for women, P=0.30).
 Almost all patients had used beta-interferon 
for a minimum of four years (except for patients 
who were diagnosed as having MS for less than 
4 years). 
 The clinical classification of the 762 patients 
were: RRMS (70%), SPMS (28%), PPMS (1%), 
and Devic’s syndrome (0.9%). Clinically isolated 
syndrome (CIS) cases were included in the RRMS 
group.
 Average daily exposure to sunlight for each 
person (in 556 cases) was 80 ± 30 min (112 ± 
60 for men and 75 ± 30 for women, P<0.001).
DISCUSSION 
Geographical variation of MS prevalence 
depends on genetics and environmental factors. 
In addition, its full and precise determination 
depends on patient access to medical care, 
number of neurologists available, application 
of new diagnostic methods, level of community 
awareness of MS, commitment to research, and 
interest of researchers. Kerman province has easy 
access to medical care, and almost all regions 
are served by a number of neurologists (with 
the exception of Kahnuj), making beta-interferon 
and immunosuppressive drugs easily available 
to patients free of charge. We believe we have 
successfully identified almost all MS cases in 
Kerman province. Based upon our evaluation, 
prevalence of MS in the province was 31.5 per 
100,000 population. Prevalence in the city of 
Kerman was 57.3 per 100,000 people, some of 
whom may have migrated from other regions. 
The prevalence in cities with cold climates was 
higher than those with milder climate, and the 
prevalence in cities with mild climate was higher 
than cities with warm climates (Table 1). The 
city of Shahrbabak, with a population of 113,938 
was the exception. In spite of cold weather, the 
prevalence of MS was low. This could be due to the 
preventive effect of copper or other factors. There 
are several copper mines and factories located in 
and around this city. In unpublished study by the 
corresponding author of this paper, it was found 
that people working in close proximity to a copper 
smelting factory had higher serum levels of copper. 
Some previous studies have found that serum 
levels of copper in MS patients are low.23 In the 
rest of the region, a linear relationship between 
frequency of MS illness and average temperature 
was observed in Figure 1.
 The ratio of men to women among our patients 
was 1:3, which could be due to men being exposed 
more to sunlight and ultraviolet radiation which 
have a protective effect. It could also be due to 
infections, immune responses, or other unknown 
factors.24-26 In a study by Alonso et al. in Iran, 
the frequency of MS decreased with increasing 
exposure to sunlight, similar to other reports.4 
In Canada, the ratio of men to women in MS is 
1:3.2.27 In USA, the ratio is 1:3, and overall the 
Table 1: Relation of prevalence of MS with mean temperature.  
City Mean   No. of 
 temperature in  Population MS MS/100000
 degree centigrade  patients 
Kerman 14.9 0852192 489 57.3
Baft 14.8 0161138 50 31
Shahrbabak 15.1 0113939 15 13.1
Rafsanjan 18.5 0327998 89 27.1
Sirjan 17.3 0273145 87 31.8
Zarand 17.5 0205739 56 27.2
Bam 23 0313702 55 17.5
Jiroft 25 0336201 48 14.2
Kahnoj 26.4 0363291 7 1.9
Kerman province 15.5 2947346 932 31.75
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prevalence of MS in women is 2 to 3 times that 
in men.4
 The average disability (EDSS) of our patients 
was 4.5 ± 1.8, with more men than women 
becoming disabled (4.8 ± 1.9 for men, and 4.3 ± 
1.8 for women, P=0.003). The average duration 
of illness was 8.2 ± 1 year (8.4 ± 1.2 for men and 
8.7 ± 0.5 for women, P=0.30). Since there was 
no significant statistical difference between men 
and women with regards to duration of illness, 
it appears that men suffered more disability, 
and the rate of progression of MS in men was 
faster than in women. One study suggests a 38% 
faster progression in males, and that younger 
age of illness onset foretells a slower rate of 
progression.28 This is in agreement with our 
finding that women tend to be afflicted earlier than 
men. In the region under study, more men than 
women smoked and there is evidence that smoking 
could intensify MS.29,30 Based on some reports, the 
average time to reach EDSS 3.5 (mild disability) 
is between 0.3-26 years.31 The advancement of 
disability with longer duration of illness is well 
recognized, and depends on individual patient, the 
gap between attacks, the type of MS, symptoms 
and signs of the first attack.22 Immunomodulatory 
or immunosuppressive drugs can reduce the 
number of attacks but their effect on long term 
disability remains controversial.32-34
 The frequency of different types of MS in this 
study was 70% RRMS, 28% SPMS, 1% PPMS, 
and 0.9% Devic’s syndrome. PPMS cases were 
low in this study, which may be partly due to 
underdiagnosis.
 In this study, the age at onset of MS was 28.4 ± 
8.5 years old, (29.7 ± 8.7 for men and 28.1 ± 8.3 
women, P<0.05). Women tended to be afflicted 
earlier than men, with the age of onset in 3.9% 
of female patients being ≤ 16 years old. The age 
of onset of MS is known to vary greatly, and may 
be due to environmental factors. The peak age 
of onset was around 30. In most studies, age of 
onset in women was earlier than in men (31.2 for 
men and 29.3 for women), with 0.7% of cases 
occurring in infants, 2.7% in adolescence, and 
2.8% in those ≥50. Other studies have reported 
early onset as occurring in 3-5% of cases.35-37
 In conclusion, we found the prevalence of 
MS in the province of Kerman to be 31.5 per 
100,000 population. A linear relationship was 
observed between prevalence of MS and average 
temperature with more cases occurring in colder 
climates. Copper may have a preventive effect 
with regards to MS since disease prevalence 
was low, despite cold temperatures, in the city 
of Shahrbabak where there are several copper 
mines and factories located in close proximity.
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